Questions raised over tamper-proof oxycodone

Tamper-proof oxycodone may not be having the desired effect as evidence emerges that patients are turning to alternative opioids.

Speaking at a Senate estimates committee hearing, earlier this week, TGA national manager, Professor John Skerritt, said initial evidence from hospital emergency departments indicated “there are more people coming in taking alternative opiates, so we have to be careful in concluding that this [tamper-free formulation] is a panacea”.

These alternatives included heroin, and “even more worryingly, fentanyl, which has